+1 year(s) experience
Manoli's current focus is on examining market trends and future developments in the fields of axial spondylarthrosis and systemic lupus erythematosus.
Working in two very different areas, Manoli has had the chance to develop a deep understanding of the dynamics operating within the healthcare sector.
Manoli came to Datamonitor Healthcare's disease team after completing a PhD in cellular and molecular biology at the University of London.
Here, Manoli specialized in muscular dystrophy, but also has experience of working in the fields of breast cancer and malaria, gained during a MRes at the University of York.
Manoli Writes For
By Manoli Kavishwar 22 Feb 2017
Enthusiasm following Benlysta's approval has died down, and there remains a considerable need for effective biologic therapies.
Topic Drug review